Why Applied Industrial Technologies (AIT) Is Up 6.3% After Raising Guidance And Authorizing New Buybacks

• In late April 2026, Applied Industrial Technologies reported third-quarter results showing higher sales and earnings per share versus a year earlier, raised its full-year EPS and sales growth guidance, authorized a repurchase of up to 3,000,000 shares, and affirmed a quarterly dividend of US$0.51 per share.
• The combination of upgraded guidance, continued capital returns through buybacks and dividends, and mixed but closely watched international revenue trends has sharpened investor focus on Applied Industrial Technologies’ earnings resilience and business mix.
• Now we’ll examine how the raised full-year earnings guidance and new share repurchase authorization affect Applied Industrial Technologies’ investment narrative.

Find 45 companies with promising cash flow potential yet trading below their fair value.

Applied Industrial Technologies Investment Narrative Recap

To own Applied Industrial Technologies, you need to believe its industrial distribution and services platform can keep generating steady earnings even when end markets are uneven. This quarter’s modest EPS improvement, raised full year guidance, and ongoing capital returns support the near term earnings resilience catalyst, while the key risk remains exposure to muted demand and volatility across legacy sectors such as machinery, utilities, and energy. Overall, the new information does not materially change that risk profile.

The new authorization to repurchase up to 3,000,000 shares is the most relevant announcement here, because it works alongside higher full year EPS guidance to concentrate per share earnings power at a time when demand visibility in several core markets is still limited. For investors focused on earnings resilience as the primary catalyst, the combination of buybacks and continued dividends at US$0.51 per share provides additional context for how Applied is choosing to return capital while operating through a mixed demand backdrop.

Yet investors should be aware that ongoing muted demand across key legacy sectors could still pressure Applied’s revenue base if...

Read the full narrative on Applied Industrial Technologies (it's free!)

Applied Industrial Technologies' narrative projects $5.6 billion revenue and $492.8 million earnings by 2029. This requires 5.1% yearly revenue growth and about a $89 million earnings increase from $403.8 million today.

Uncover how Applied Industrial Technologies' forecasts yield a $330.00 fair value, a 5% upside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community span roughly US$214 to US$330 per share, underscoring how far apart individual views can be. Against that backdrop, the raised full year EPS guidance and new buyback authorization sharpen the debate around how much muted demand in legacy end markets might cap Applied’s longer term earnings power, so it is worth considering several of these alternative viewpoints before drawing conclusions.

Explore 4 other fair value estimates on Applied Industrial Technologies - why the stock might be worth as much as $330.00!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Applied Industrial Technologies research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Applied Industrial Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Applied Industrial Technologies' overall financial health at a glance.

Looking For Alternative Opportunities?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.
• AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com